Reductions in hospitalisations and emergency department visits with early antibiotic initiation in nontuberculous mycobacterial lung disease

被引:0
|
作者
Winthrop, Kevin [1 ,2 ]
Waweru, Catherine [3 ]
Hassan, Mariam [3 ]
Burns, Sara [4 ]
Lucci, Matthew [4 ]
Chatterjee, Anjan [3 ]
机构
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Portland State Univ, Sch Publ Hlth, Portland, OR 97207 USA
[3] Insmed Inc, Bridgewater Township, NJ USA
[4] Panalgo, Boston, MA USA
关键词
PULMONARY-DISEASE; AVIUM COMPLEX; DIAGNOSIS; MORTALITY; IMPACT;
D O I
10.1183/23120541.00963-2023
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background While antibiotics are recommended for treatment of nontuberculous mycobacterial lung disease (NTMLD), the impact of early antibiotic initiation on healthcare resource utilisation is unclear. This study compared healthcare resource utilisation with early versus delayed antibiotic initiation in NTMLD. Methods A retrospective, claims database study (Merative MarketScan) of patients diagnosed with NTMLD between 1 July 2015 and 30 June 2019. Patients were divided into early antibiotic initiation, i.e. <= 3 months after the first medical claim for NTMLD (index date), and delayed antibiotic initiation groups. Hospitalisations and outpatient visits during a 2-year post-index period were compared to baseline per treatment group; a difference-in-difference analysis compared early and delayed antibiotic initiation groups adjusting for confounding. Results Out of 481 NTMLD treated patients, 364 (76%) and 117 (24%) comprised the early and delayed antibiotic initiation groups, respectively. The early antibiotic initiation group showed significant reductions from baseline in hospitalisations (all-cause, respiratory) and emergency department (ED) visits at follow-up. A significant increase from baseline in mean number of hospitalisations per patient was observed in the delayed antibiotic initiation group in year 1 post-index. Compared to delayed antibiotic initiation, the early antibiotic initiation group showed significantly greater reductions in all-cause hospitalisations in years 1 and 2 post-index (relative risk 0.62 (95% CI 0.41-0.95) and 0.62 (95% CI 0.39-0.98), respectively), and in respiratory-related hospitalisations. Conclusions The early antibiotic initiation group showed significant reductions from baseline in hospitalisations and ED visits over time. Compared to delayed antibiotic initiation, early antibiotic initiation was associated with significantly greater reductions in hospitalisations.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Therapeutic developments for tuberculosis and nontuberculous mycobacterial lung disease
    Dartois, Veronique
    Dick, Thomas
    NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (05) : 381 - 403
  • [22] Pathogenesis and Risk Factors for Nontuberculous Mycobacterial Lung Disease
    Honda, Jennifer R.
    Knight, Vijaya
    Chan, Edward D.
    CLINICS IN CHEST MEDICINE, 2015, 36 (01) : 1 - 11
  • [23] Reduction in hospitalisations and emergency department visits for frail patients with heart failure: Results of the UMIPIC healthcare programme
    Cerqueiro, J. M.
    Gonzalez-Franco, A.
    Montero-Perez-Barquero, M.
    Llacer, P.
    Conde, A.
    Davila, M. F.
    Carrera, M.
    Serrado, A.
    Suarez, I.
    Perez-Silvestre, J.
    Satue, J. A.
    Arevalo-Lorido, J. C.
    Rodriguez, A.
    Herrero, A.
    Jordana, R.
    Manzano, L.
    REVISTA CLINICA ESPANOLA, 2016, 216 (01): : 8 - 14
  • [24] The impact of nontuberculous mycobacterial lung disease in critically ill patients: Significance for survival and ventilator use
    Chien, Ying-Chun
    Chang, Chin-Hao
    Huang, Chun-Kai
    Chen, Yung-Hsuan
    Liu, Chia-Jung
    Chen, Chung-Yu
    Wang, Ping-Huai
    Shu, Chin-Chung
    Kuo, Lu-Cheng
    Wang, Jann-Yuan
    Ku, Shih-Chi
    Wang, Hao-Chien
    Yu, Chong-Jen
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2024, 57 (02) : 328 - 336
  • [25] Aspergillus isolation in nontuberculous mycobacterial pulmonary disease: Associated with antimycobacterial treatment initiation but not response
    Raats, Daan
    Aldhaheri, Sharina M. S.
    Marras, Theodore K.
    Mehrabi, Mahtab
    Brode, Sarah K.
    RESPIRATORY MEDICINE, 2021, 179
  • [26] Extensive Lung Resection for Nontuberculous Mycobacterial Lung Disease With Multilobar Lesions
    Yamada, Katsuo
    Seki, Yukio
    Nakagawa, Taku
    Hayashi, Yuta
    Yagi, Mitsuaki
    Sano, Masahiro
    Ogawa, Kenji
    ANNALS OF THORACIC SURGERY, 2021, 111 (01) : 253 - 260
  • [27] Hemoptysis requiring bronchial artery embolization in patients with nontuberculous mycobacterial lung disease
    Lee, Su Hwan
    Lee, Jin Hwa
    Chang, Jung Hyun
    Kim, Soo Jung
    Yoon, Hee-Young
    Shim, Sung Shine
    Kim, Min Uk
    Choi, Sun Young
    Ryu, Yon Ju
    BMC PULMONARY MEDICINE, 2019, 19 (1)
  • [28] Diagnosis of Pulmonary Tuberculosis and Nontuberculous Mycobacterial Lung Disease in Korea
    Kwon, Yong Soo
    Koh, Won-Jung
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2014, 77 (01) : 1 - 5
  • [29] HLA Antigens and Nontuberculous Mycobacterial Lung Disease in Korean Patients
    Um, Sang-Won
    Ki, Chang-Seok
    Kwon, O. Jung
    Koh, Won-Jung
    LUNG, 2009, 187 (02) : 136 - 140
  • [30] Underlying Host Risk Factors for Nontuberculous Mycobacterial Lung Disease
    Chan, Edward D.
    Iseman, Michael D.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 34 (01) : 110 - 123